Stay updated on Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page.

Latest updates to the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, representing an updated version of the study page. This change is a metadata version bump and does not modify the substantive study details.SummaryDifference0.0%

- Check26 days agoChange DetectedThese changes reflect updates to the study record's update history, with May 2026 timestamps added and April 2026 timestamps removed. They indicate edits to the page's metadata rather than changes to the study's design, eligibility, or outcomes.SummaryDifference0.1%

- Check33 days agoChange DetectedTwo trial sites were updated: Liuzhou, China (545026) and Taoyuan, Taiwan (33382) were added, while Liuchow, China (545026) and Taoyuan District, Taiwan (33382) were removed.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page’s footer “Revision” indicator is updated from v3.5.2 to v3.5.3, reflecting a minor update to the site software/versioning without changing the displayed trial content.SummaryDifference0.0%

- Check47 days agoChange DetectedAdditions: 2026-04-13, 2026-04-09, 2026-04 and Revision: v3.5.2. Deletions: 2026-03-16, 2026-03-12, 2026-03 and Revision: v3.5.0.SummaryDifference0.1%

- Check62 days agoChange DetectedPadova, Italy, 35128 has been added to the locations and Padua, Italy, 35128 has been removed.SummaryDifference0.0%

Stay in the know with updates to Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page.